cDNA cloning and gene expression of human type Iα cGMP-dependent protein kinase

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 552-557

  Tamura, Naohisa ^a   Itoh, Hiroshi ^a   Ogawa, Yoshihiro ^a   Nakagawa, Osamu ^a   Harada, Masaki ^a   Chun, Tae Hwa ^a   Suga, Shin Ichi ^a   Yoshimasa, Takaaki ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

angiotensin II; cloning, molecular; growth substances; muscle, smooth, vascular; platelet derived growth factor; protein kinases

Indexed keywords

ANGIOTENSIN; CYCLIC GMP; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE;

ANIMAL CELL; ATHEROSCLEROSIS; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOBLOTTING; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; VASCULAR SMOOTH MUSCLE;

EID: 0029915360     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.552     Document Type: Conference Paper

References (20)

1. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in cardiovascular system. Rev Physiol Biochem Pharmacol. 1989;113:42-88.
2. Butt E, Geiger J, Jarchau T, Lohmann SM, Walter U. The cGMP-dependent protein kinase: gene, protein, and function. Neurochem Res. 1993;18:27-42.
3. Ruth P, Wang G-X, Boekhoff I, May B, Pfeifer A, Penner R, Korth M, Breer H, Hofmann F. Transfected cGMP-dependent protein kinase suppresses calcium transients by inhibition of inositol 1,4,5-triphosphate production. Proc Natl Acad Sci U S A. 1993;90: 2623-2627.
4. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-triphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem. 1994;269:8701-8707.
5. 2+-ATPase by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1987;84:5685-5689.
6. Nakao, K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system I. J Hypertens. 1992; 10:907-912.
7. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, Takemura G, Fujiwara H, Sugawara A, Yamada T, Itoh H, Mukoyama M, Hosoda K, Kawai C, Ban T, Yasue H, Imura H. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989;83:298-305.
8. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
9. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of 'vascular natriuretic peptide system.' J Clin Invest. 1992;90:1145-1149.
10. Komatsu Y, Nakao K, Itoh H, Suga S, Ogawa Y, Imura H. Vascular natriuretic peptide. Lancet. 1992;340:622.
11. Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells: evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993;133:3038-3041.
12. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
13. Itoh H, Pratt RE, Dzau VJ. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 1990;86: 1690-1697.
14. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J. 1993;7:328-338.
15. Wernet W, Flockerzi V, Hoffman F. The cDNA of two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett. 1989;251: 191-196.
16. Sandberg M, Natarajan V, Ronander I, Kalderon D, Walter U, Lohmann SM, Jahnsen T. Molecular cloning and predicted full-length amino acid sequence of the type Iβ isozyme of cGMP-dependent protein kinase from human placenta. FEBS Lett. 1989; 255:321-329.
17. Bloch KD, Struhl K, Tabor S, Seharf SJ, Gelfand DH, Boyle A. Enzymatic manipulation of DNA and RNA. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York, NY: John Wiley & Sons Inc; 1991:3.0.1-3.18.7.
18. Hanks SK, Lawton MA. Homology-based approaches for identifying cDNAs that encode eukaryotic protein (serine/threonine) and protein (tyrosine) kinases. In: Hardie DG, ed. Protein Phosphorylation. Oxford, UK: Oxford University Press; 1993:173-196.
19. Sandberg M, Natarajan V, Orstavik S, Lohmann SM, Jahnsen T. The human type I cGMP-dependent protein kinase gene. In: Ross EM, Wirtz KWA, eds. Biological Signal Transduction. Berlin, FRG: Springer-Verlag; 1991:301-308.
20. Boerth NJ, Lincoln TM. Expression of the catalytic domain of cyclic GMP-dependent protein kinase in a vaculovirus system. FEBS Lett. 1994;342:255-260.